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All data in this report are preliminary and subject to change as more information is received. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Highlights from this week’s report: 
• There is still time to get a flu shot to ensure you are protected as flu activity continues. 
• Influenza-like illness activity in Massachusetts remains high this week and is consistent with activity 
levels normally seen at this time of year  
• Geographic spread is widespread: ILI activity and influenza laboratory confirmations are increased in 
all regions of the state. 
• Influenza-associated hospitalizations in Massachusetts remain elevated this week and are consistent 
with activity levels normally seen at this time of year. 
• The number of influenza positive laboratory tests reported to MDPH increased this week by 19.8% 
• For the 2018-2019 season to date, the predominant influenza strain is A/2009 H1N1; this may 
fluctuate as the season continues. 
• All influenza strains that have been characterized in Massachusetts this season to date are covered 
by the current influenza vaccine. 
• No resistance to antiviral medications has been detected this season. 
• Nationally, flu activity remains high, consistent with normal levels of activity at this time of year. 
• Additional data are available upon request and at www.cdc.gov/flu/weekly. 
 2 
Influenza-like illness activity  
Influenza-like illness (ILI) is defined as fever above 100F in addition to either cough or sore throat. Many more people are 
infected with influenza than are tested for influenza. ILI is used throughout the regular influenza season as a way to help 
track influenza activity in individuals who are not tested, as trends in ILI have been shown to mirror influenza trends.  Sixty 
healthcare facilities called ‘sentinel sites’, including provider offices, school health services, community health centers, 
and emergency departments across Massachusetts report the number of patients they see with ILI each week during 
regular flu season.  
 
Figure 1 shows that ILI activity is high and is consistent with activity levels normally seen at this time of year. For more 
information, see CDC’s influenza surveillance website at www.cdc.gov/flu/weekly/fluactivitysurv.htm. 
 
 
 
 3 
Influenza-associated hospitalizations 
As part of the National Syndromic Surveillance Program, MDPH receives data from Emergency Departments (EDs) 
covering more than 90% of ED visits statewide. These data are used to track patient visits related to influenza by 
monitoring the reason patients are seeking care (chief complaint) and the diagnoses the patients receive (ICD-10 code). 
These data are available to MDPH in near real-time. 
 
Figure 2 shows the percent of all ED visits which result in the patient being hospitalized that are associated with influenza 
infection. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4 
Regional ILI activity 
Figure 3 shows the relative intensity of reported ILI activity in Massachusetts by region. Although regions may not all 
experience the same intensity of ILI at similar times, infections due to influenza can be found throughout Massachusetts 
during flu season. Figure 3 shows that all seven regions of the state are reporting increased ILI activity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 5 
Laboratory testing for influenza 
Laboratories in Massachusetts report all positive influenza test results to MDPH. The majority of individuals with 
influenza-like illness are not tested; therefore the number of positive test results does not reflect the total number of 
influenza cases in Massachusetts. However, laboratory data do provide information about the types of influenza virus 
circulating in Massachusetts and help indicate the presence and define the distribution of influenza in the state.  Figure 3 
illustrates the number of positive laboratory confirmed influenza cases in Massachusetts by week. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 6 
Testing at the State Public Health Laboratory 
The Massachusetts State Public Health Laboratory (MA SPHL) performs influenza surveillance testing year round to 
confirm circulating influenza virus types. Samples are submitted by outpatient healthcare providers (ILINet) and hospital 
diagnostic laboratories in Massachusetts.  For the 2018-2019 season, Table 1 summarizes the influenza surveillance 
testing conducted by MA SPHL beginning September 30, 2018.  For the 2018-2019 season so far, the predominant 
influenza strain is A/2009 H1N1; this may fluctuate as the season continues. 
 
Table 1: Weekly Summary of Massachusetts State Public Health Laboratory Influenza Surveillance Test 
Results 
2018-2019 Season: Influenza Surveillance 
Week 2009  H1N1 
seasonal 
A/H3N2 H3N2v B Yam B Vic 
No. Flu Pos 
(%) Unsat 
Total 
Tested 
Total 
Rec’d 
03 (01/13 – 01/19/19) 56 4 0 1 0 61(87%) 1 70 71 
04 (01/20 – 01/26/19) 45 2 0 0 0 47(78%) 0 60 60 
05 (01/27 – 02/02/19) 64 3 0 0 0 67(89%) 4 75 79 
06 (02/03 – 02/09/19) 32 4 0 0 0 36(78%) 0 46 46 
Prior 4 wk Total 197 13 0 1 0 211(84%) 5 251 256 
Cumulative Season total 269 16 0 3 0 288(72%) 13 398 411 
All data are subject to change as test results become finalized. The 2018 -2019 influenza season began the week of 09/30- 10/06/2018. 
 
 
All specimens which test negative for influenza at MA SPHL are also tested for non-influenza respiratory diseases. Table 2 
shows that viruses from rhinovirus (RHV)/enterovirus (ENT) and coronavirus (HCoV) groups are currently circulating in 
Massachusetts. This contributes to ILI trends in Massachusetts. 
 
Table 2: Weekly Summary of Massachusetts State Public Health Laboratory non-Influenza Respiratory 
Surveillance Test Results 
2018-2019 Season: Influenza Like Illness Surveillance 
Week: RSV RHV/ENT PIV HMPV HCoV ADV 
# Co-
Infection 
No. Pos 
(%) Unsat 
Total 
Tested 
Total 
Rec’d 
03 (01/13 – 01/19/19) 1 0 0 0 4 0 0 5(56%) 0 9 9 
04 (01/20 – 01/26/19) 1 0 1 0 5 1 0 8(67%) 0 12 12 
05 (01/27 – 02/02/19) 0 0 1 0 2 0 0 3(38%) 0 8 8 
06 (02/03 – 02/09/19) 0 1 0 1 4 0 0 6(60%) 0 10 10 
Prior 4 wk Total 2 1 2 1 15 1 0 22(56%) 0 39 39 
Cumulative Season total 4 10 3 1 19 2 0 39(37%) 0 106 106 
All data are subject to change as test results become finalized. The 2018 -2019 influenza season began the week of 9/30- 10/06/2018. 
 
 
MA SPHL submits a subset of influenza samples to CDC for further genetic analysis (antigenic characterization).  All strains 
that have been analyzed from Massachusetts this season are covered by the current influenza vaccine. 
 
Every two weeks MASPHL screens influenza specimens to detect mutations within influenza A/H3N2 and A/2009 H1N1 
viruses to look for antiviral resistance. No mutations have been identified in the 2018-2019 season. 
 
Additional information on national antiviral resistance testing including recommendations for antiviral treatment and 
chemoprophylaxis of influenza virus infection can be found at http://www.cdc.gov/flu/weekly/. 
 
